Seer to Present at the Cowen 41st Annual Healthcare Conference
February 24 2021 - 4:05PM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
be participating in the upcoming Cowen 41st Annual Healthcare
Conference.
Seer’s management is scheduled to participate in
a fireside chat on Wednesday, March 3 at 8:40 a.m. Pacific Time /
11:40 a.m. Eastern Time. A live webcast of the virtual session will
be available on the Investor section of Seer’s website at
investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About SeerSeer™ is a life sciences company
focused on enabling exceptional scientific outcomes by
commercializing transformative products that will drive
breakthrough ideas by unlocking the deep, unbiased biological
information that can make them a reality. Seer is developing its
Proteograph™ Product Suite, which is an integrated solution
consisting of consumables, automation instrumentation and
proprietary software that performs deep, unbiased proteomics
analysis at scale in a matter of hours. Seer designed the
Proteograph to be efficient and easy-to-use, leveraging widely
adopted laboratory instrumentation to provide a decentralized
solution broadly available to life sciences researchers. Seer’s
Proteograph Product Suite is for research use only and is not
intended for diagnostic procedures. For more information, please
visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024